Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBAGR.L Regulatory News (BAGR)

  • There is currently no data for BAGR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Banking update

4 Jan 2016 07:00

RNS Number : 6359K
Bagir Group Ltd
04 January 2016
 

Bagir Group Ltd.

("Bagir" or the "Company")

Banking update

 

Bagir (AIM: BAGR), a designer, creator and provider of innovative tailoring, is pleased to announce that it has secured the agreement of its banks, Leumi Bank and Discount Bank (the "Banks"), to an amended repayment schedule. At the same time, the Company has also secured the agreement of the banks to a waiver of the testing of Company's financial covenants for 31 December 2015 and 30 June 2016.

 

Eran Itzhak, CEO, commented: "I am extremely pleased to be able to announce that we have reached this agreement with our bankers which reflects their continued trust and support.

 

"The waiver of the testing of the covenants is of immediate importance but of equal, if not more, significance is that we have secured their agreement to a three year extension of the repayment terms of the loans and the reclassification of the previous short-term revolving 12 month loan to a long-term facility. This provides us with increased financial security as we continue to seek to rebuild the Company."

 

The major agreed terms are as follows:

 

Amended repayment schedule

The repayment schedule for the $11.2 million long-term loan has been amended as follows:

 

 

Rescheduled (US$ in thousands)
Original (US$ in thousands)
Year
465
2,700
2016
750
4,000 + 4,537 on 31.12.2017
2017
1,000
 
2018
1,700
 
2019
2,300 + 5,022 on 31.12.2020
 
2020

 

There is also an amendment to the customary accelerated repayment terms.

 

Reclassification of short-term loan

The current short-term revolving 12 month loan of US$10 million with final repayment date on 31 December 2017 will be reclassified as a long-term loan with the next revolving date being deferred to 1 January 2018. Thereafter, annual renewals will take place until 31 December 2020 subject to the Company complying with the debt arrangement terms.

 

Waiver and amendment of banking covenants

The Banks have agreed to waive covenant tests at both 31 December 2015 and 30 June 2016. Thereafter a revised set of covenants have been agreed on more favourable terms to the Company than previously. These revised covenants will continue to be tested every six months.

 

Dividend distributions

No dividends can be made by the Group without the consent of the Banks until 31 December 2020 at the earliest.

 

Bank share options

New share options over in aggregate 166,667 ordinary shares of NIS 0.04 each are to be granted to the Banks at the market price on the date of grant. At the same time, the existing share options over in aggregate 100,000 ordinary shares of NIS 0.04 each are to be amended so that the exercise price will be the market price on the date of grant.

 

Both the grant of new share options and the amendment of the existing share options will be subject to shareholders approval and further announcements will be made in this regard.

 

For further information, please contact:

 

Bagir Group Ltd.

Eran Itzhak, Chief Executive Officer

Udi Cohen, Chief Financial Officer

Tessa Laws, Non-Executive Chairman

 

 

+972-8-687-3917

N+1 Singer

Nic Hellyer

Alex Price

Alex Wright

 

+44 (0)20 7496 3000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEANFDEFFKEEF
Date   Source Headline
18th May 20205:30 pmRNSBagir Group
18th May 202012:10 pmRNSAppointment of Liquidator
22nd Apr 20207:00 amRNSAppointment of Court Trustees
14th Apr 20207:00 amRNSFinancial Update
3rd Apr 20207:30 amRNSSuspension - Bagir Group Ltd
3rd Apr 20207:30 amRNSFinancial Update
31st Mar 20207:00 amRNSHolding(s) in Company
25th Mar 202012:00 pmRNSCOVID-19 Update
23rd Mar 20209:03 amRNSHolding(s) in Company
17th Mar 20201:24 pmRNSHolding(s) in Company
16th Mar 20208:20 amRNSHolding(s) in Company
2nd Mar 202011:20 amRNSHolding(s) in Company
21st Feb 20207:00 amRNSUpdate on status with Shandong Ruyi and 19 Trading
13th Feb 20208:18 amRNSResignation of Chairperson
21st Jan 20207:55 amRNSHolding(s) in Company
13th Dec 20192:06 pmRNSHolding(s) in Company
2nd Dec 201911:02 amRNSResult of AGM
29th Nov 20198:20 amRNSHolding(s) in Company
22nd Oct 20199:46 amRNSNotice of AGM
7th Oct 20199:17 amRNSHolding(s) in Company
3rd Oct 20194:40 pmRNSSecond Price Monitoring Extn
3rd Oct 20194:35 pmRNSPrice Monitoring Extension
2nd Oct 20193:29 pmRNSHolding(s) in Company
2nd Oct 20193:20 pmRNSHolding(s) in Company
26th Sep 20197:00 amRNSHalf-year Report
10th Sep 201911:30 amRNSHolding(s) in Company
10th Sep 201910:55 amRNSHolding(s) in Company
5th Sep 201910:35 amRNSHolding(s) in Company
23rd Aug 20193:08 pmRNSHolding(s) in Company
19th Aug 20193:48 pmRNSHolding(s) in Company
12th Aug 20193:49 pmRNSHolding(s) in Company
12th Aug 20198:49 amRNSHolding(s) in Company
28th Jun 20197:00 amRNSPosting of Annual Report
25th Jun 20197:00 amRNSDirectorate Change
19th Jun 20197:00 amRNSUpdate on Strategic Partnership and Trading
31st May 201911:05 amRNSSecond Price Monitoring Extn
31st May 201911:00 amRNSPrice Monitoring Extension
31st May 20197:00 amRNSUpdate on Strategic Partnership
28th May 20192:05 pmRNSSecond Price Monitoring Extn
28th May 20192:00 pmRNSPrice Monitoring Extension
20th May 20194:40 pmRNSSecond Price Monitoring Extn
20th May 20194:35 pmRNSPrice Monitoring Extension
13th May 20197:00 amRNSDirectorate Change
4th Apr 20197:00 amRNSFinal Results
22nd Mar 201912:01 pmRNSHolding(s) in Company
15th Feb 201910:38 amRNSHolding(s) in Company
13th Feb 20192:00 pmRNSPrice Monitoring Extension
13th Feb 20197:00 amRNSUpdate on strategic partnership
3rd Jan 20192:05 pmRNSSecond Price Monitoring Extn
3rd Jan 20192:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.